Chemomab Therapeutics Ltd. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Chemomab Therapeutics Ltd. (CMMB) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $22.00 thousand as of 2024-12-31, per its 20-F filed 2025-04-04.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2025-04-04
- 2024-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $22.00K.
- 2023-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $72.00K.
- 2022-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $5.00K.
- 2021-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $28.00K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2024-12-31 | $22.00K 20-F · filed 2025-04-04 |
| 2023-12-31 | $72.00K 20-F · filed 2024-03-28 |
| 2022-12-31 | $5.00K 10-K · filed 2023-03-20 |
| 2021-12-31 | $28.00K 10-K · filed 2022-03-30 |
| 2020-12-31 | $10.00K 10-K · filed 2021-03-09 |
| 2019-12-31 | $84.00K 10-K · filed 2020-03-17 |